Browsing Tag
European Commission
245 posts
Bristol Myers Squibb gets Reblozyl EC approval for anemia associated with NTD beta thalassemia
Bristol Myers Squibb (BMY) has secured full marketing authorization for Reblozyl (luspatercept) from the European Commission (EC) for…
March 4, 2023
CSL Behring bags Hemgenix EC approval for treatment of Hemophilia B
German-based biotechnology company CSL Behring has received conditional marketing authorization (CMA) from the European Commission (EC) for its…
February 22, 2023
Sanofi, Regeneron get Dupixent EC approval for eosinophilic esophagitis
French pharmaceutical company Sanofi and Regeneron, an American biotechnology company, have received the approval of the European Commission…
February 1, 2023
Novartis gets Pluvicto EC approval for advanced prostate cancer
Novartis has received the approval of the European Commission (EC) for Pluvicto (lutetium (177Lu) vipivotide tetraxetan), a targeted…
December 15, 2022
Takeda gets QDENGA EC approval as dengue vaccine
Takeda has received the European Commission’s (EC) marketing authorization for the company’s dengue vaccine QDENGA (Dengue Tetravalent Vaccine…
December 12, 2022
EU launches full-scale investigation into Microsoft, Activision deal
The European Commission has launched a full-scale phase 2 investigation to evaluate the previously announced acquisition of Activision…
November 11, 2022
Greece-Bulgaria Interconnection gas pipeline : IGI Poseidon begins commercial operation
IGI Poseidon, through its subsidiary ICGB AD, has commenced commercial operation of the Greece-Bulgaria Interconnection gas pipeline (IGB)…
October 3, 2022
Cara Therapeutics, VFMCRP get EC approval for Kapruvia for pruritus
Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) said that Kapruvia (difelikefalin) has secured approval from…
May 1, 2022
Chinook Therapeutics gets orphan drug status from EC for atrasentan in IgAN
Chinook Therapeutics, a US-based biopharma company, has secured orphan drug designation for atrasentan from the European Commission (EC)…
December 15, 2021
EC approves sale of Aegon’s CEE businesses to Vienna Insurance
The European Commission (EC) has approved the €830 million sale of Dutch insurance group Aegon’s Central and Eastern…
August 13, 2021